Response assessment in acute myeloid leukemia by flow cytometry supersedes cytomorphology at time of aplasia, amends cases without molecular residual disease marker and serves as an independent prognostic marker at time of aplasia and post-induction
Thomas Köhnke,
Veit Bücklein,
Sandra Rechkemmer,
Stephanie Schneider,
Maja Rothenberg-Thurley,
Klaus H. Metzeler,
Maria-Cristina Sauerland,
Wolfgang Hiddemann,
Karsten Spiekermann,
Marion Subklewe
Affiliations
Thomas Köhnke
Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich;Translational Cancer Immunology, Gene Center, LMU Munich, Munich
Veit Bücklein
Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich;Translational Cancer Immunology, Gene Center, LMU Munich, Munich
Sandra Rechkemmer
Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich
Stephanie Schneider
Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich;Institute of Human Genetics, LMU Munich, Munich
Maja Rothenberg-Thurley
Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich;German Cancer Consortium (DKTK), Heidelberg;German Cancer Research Center (DKFZ), Heidelberg
Klaus H. Metzeler
Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich;German Cancer Consortium (DKTK), Heidelberg;German Cancer Research Center (DKFZ), Heidelberg
Maria-Cristina Sauerland
Institute of Biostatistics and Clinical Research, University of Münster, Münster, Germany
Wolfgang Hiddemann
Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich;German Cancer Consortium (DKTK), Heidelberg;German Cancer Research Center (DKFZ), Heidelberg
Karsten Spiekermann
Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich;German Cancer Consortium (DKTK), Heidelberg;German Cancer Research Center (DKFZ), Heidelberg
Marion Subklewe
Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich;Translational Cancer Immunology, Gene Center, LMU Munich, Munich;German Cancer Consortium (DKTK), Heidelberg;German Cancer Research Center (DKFZ), Heidelberg
